Rita C. Guedes

Av. Rovisco Pais 1
Lisbon, 1049001, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

Journal: International journal of molecular sciences
Published: March 16, 2026

In Silico to In Cerebro-Development of the Orexin Receptor Antagonist "Photorexant" for Photomodulation In Vitro and in Mouse Brains.

In Silico to In Cerebro-Development of the Orexin Receptor Antagonist "Photorexant" for Photomodulation In Vitro and in Mouse Brains.

Journal: Angewandte Chemie (International ed. in English)
Published: January 16, 2026

Validation of a Tool for the Assessment of Discomfort in Patients With Impaired Cognition in Palliative Care.

Validation of a Tool for the Assessment of Discomfort in Patients With Impaired Cognition in Palliative Care.

Journal: The American journal of hospice & palliative care
Published: October 31, 2025

Design, Synthesis, and Evaluation of New Polyhydroxylated Bis-Chalcones as Potential COX-2 Selective Inhibitors.

Design, Synthesis, and Evaluation of New Polyhydroxylated Bis-Chalcones as Potential COX-2 Selective Inhibitors.

Journal: ChemMedChem
Published: September 12, 2025

Real-World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2-Year Portuguese Multicenter Retrospective Cohort Study.

Real-World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2-Year Portuguese Multicenter Retrospective Cohort Study.

Journal: International journal of dermatology
Published: June 06, 2025

Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs.

Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs.

Journal: Antioxidants (Basel, Switzerland)
Published: May 14, 2025

Synthesis and biological evaluation of novel carnosic acid derivatives with anticancer activity.

Synthesis and biological evaluation of novel carnosic acid derivatives with anticancer activity.

Journal: RSC advances
Published: April 08, 2025

Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I.

Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I.

Journal: Molecular therapy. Oncology
Published: March 21, 2025

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 21, 2025

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 17, 2024

Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity.

Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity.

Journal: Pharmaceutics
Published: November 18, 2024

Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity.

Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity.

Journal: International journal of molecular sciences
Published: October 05, 2024
Showing 1-12 of 81

Last Updated: 09/26/2026